To ensure that a progressive tauopathy forms via an acK280-mediated aggregation at a molecular level, we introduced a similar mutation in K18, in which a residue corresponding to K280 of tau was mutated to alanine (K18K280A). The gene discussed is MAPT; the disease is tauopathy.